Nefense®, a leader in advanced clinical hygiene and airway health solutions, announced the launch of its Hypochlorous Acid (HOCl) nasal spray line. The product family includes Hyponasal, Hyponasal Junior, and Hypobaby, designed to support respiratory wellness across all ages. These drug-free sprays aim to provide safe, effective nasal care without harsh chemicals, medications, or steroids.
The flagship product, Hyponasal HOCl Nose Spray, is formulated as a biocleanse for nasal passages. It helps flush away environmental irritants while supporting natural respiratory defenses. According to Dr. Richard D. Downs, D.D.S., "Proper airway management begins with maintaining a clean and healthy nasal cavity. With Hyponasal, we are providing a superior biocleanse solution that addresses daily irritation at its source."
The active ingredient, Ionoxx Hypochlorous Acid (HOCl), is a molecule naturally produced by the immune system. Known for its antimicrobial and anti-inflammatory properties, HOCl helps maintain a cleaner nasal environment and promotes healthy respiratory function. Dr. Joseph Zelk, a sleep specialist collaborating with Nefense, noted, "The anti-inflammatory and antimicrobial properties of HOCl make it a remarkable tool for naturally clearing the airway, mitigating allergies, and supporting healthier breathing."
For pediatric use, Hyponasal Jr. and Hypobaby offer age-specific formulations that deliver the same cleansing technology tailored for children and infants. Dr. Shane Smith emphasized, "Parents constantly struggle to find safe, drug-free solutions for their children’s congestion. Hypobaby and Hyponasal Jr. offer unparalleled peace of mind."
The launch addresses growing consumer interest in respiratory wellness, including airway hygiene, allergy management, and drug-free nasal care. With this expansion, Nefense continues to provide science-driven products for healthy breathing. For more information, visit Nefense.com.
